Register entryShortage reported
Medefil, Inc.
- Registered sites
- 1
- Drug products
- 4
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackagingRelabellingRepackagingsterilize
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Medefil, Inc. | Glendale Heights, ILUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging, sterilize | 3001677091 |
Alert
Products in shortage
2| Drug | Presentation | Availability |
|---|---|---|
| Atropine Sulfate Injection | Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Available |
| Sterile Water Injection | Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30) | Available |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Atropine Sulfate | Atropine Sulfate Injection | INJECTION, SOLUTION | ANDA |
| Calcium Chloride | Calcium Chloride Injection | INJECTION, SOLUTION | ANDA |
| Sterile Water | Sterile Water for Injection | INJECTION, SOLUTION | ANDA |
| sodium chloride | SODIUM CHLORIDE | INJECTION, SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.